Open AccessS217: PRELIMINARY ANALYSIS OF THE PHASE II STUDY USING TOLINAPANT (ASTX660) MONOTHERAPY IN 98 PERIPHERAL T‐CELL LYMPHOMA AND 51 CUTANEOUS T‐CELL LYMPHOMA SUBJECTS WITH RELAPSED REFRACTORY DISEASE.
Author(s) -
Michot J.M.,
Mehta A.,
Samaniego F.,
Bachy E.,
Zinzani P. L.,
Prica A.,
Colins G. P.,
Ribrag V,
WagnerJohnston N.,
ElSharkawi D.,
O'Connor O. A.,
Wilcox R.,
Wang L.,
Wilson L.,
Sims M.,
Taylor J. A.,
Keer H. N.,
Foss F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843760.14993.43
Subject(s) - medicine , lymphoma , cutaneous t cell lymphoma , adverse effect , oncology , phases of clinical research , clinical endpoint , dosing , refractory (planetary science) , cancer , peripheral t cell lymphoma , gastroenterology , t cell , chemotherapy , clinical trial , immunology , mycosis fungoides , immune system , physics , astrobiology